Offer - Urjas Oil for just ₹ 1 X
Lemolate (Yash), a prescription drug, is manufactured in various forms such as Drops, Tablet. Primarily, it is used for the treatment of Common Cold. The alternative uses of Lemolate (Yash) have also been explained below.
The optimal dosage of Lemolate (Yash) is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Lemolate (Yash) side effects, there are can be others also. These have been listed below. Normally, these side effects of Lemolate (Yash) are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Lemolate (Yash) has a Moderate effect for pregnant women and Mild effect on lactating mothers. It is important to know if Lemolate (Yash) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Lemolate (Yash) related warnings section.
Lemolate (Yash) is contraindicated in people with pre-existing medical conditions like Heart Disease as it can result in adverse effects. The section on Lemolate (Yash) contraindications lists all such conditions.
Drug reaction of Lemolate (Yash) with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Lemolate (Yash) is not safe while driving, and is is not addictive in nature.
Lemolate (Yash) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Lemolate (Yash) safe for pregnant women?
Lemolate (Yash) may have some side effects during pregnancy. Pregnant women should discontinue the use of Lemolate (Yash), and talk to their doctor, if they notice any discomfort.
Is the use of Lemolate (Yash) safe during breastfeeding?
Side effects of Lemolate (Yash) on breastfeeding women are very mild.
What is the effect of Lemolate (Yash) on the Kidneys?
Very few cases of side effects of Lemolate (Yash) on kidney have been reported.
What is the effect of Lemolate (Yash) on the Liver?
Lemolate (Yash) is rarely harmful for the liver.
What is the effect of Lemolate (Yash) on the Heart?
Side effects of Lemolate (Yash) rarely affect the heart.
Lemolate (Yash) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lemolate (Yash) unless your doctor advises you to do so -
Is this Lemolate (Yash) habit forming or addictive?
No, you will not get addicted to Lemolate (Yash).
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Lemolate (Yash) as you may feel sleepy.
Is it safe?
Lemolate (Yash) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Lemolate (Yash) in mental disorders is not effective.
Interaction between Food and Lemolate (Yash)
Taking Lemolate (Yash) with food is safe.
Interaction between Alcohol and Lemolate (Yash)
Due to lack of research, there is no information about the side effects of taking Lemolate (Yash) with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vazculep (phenylephrine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 135-136
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1020-1022